Senegal Sets the Pace for West Africa’s Regulatory Maturation

Senegal’s pharmaceutical regulator, ARP, launched its digital platform for registering medicines and health products on 23 October, aiming for faster dossier processing, better traceability and more transparency. ARP’s National Vigilance Commission also concluded that serious adverse events reported in healthcare institutions were linked to iohexol and bupivacaine, and issued recommendations to prevent them happening again. ARP is also validating priority regulatory texts to consolidate its WHO Maturity Level 3 status on the way to ML4, while the African Medicines Agency and EMA jointly trained 21 francophone African regulators in Kigali on harmonised practice.

High-Level Impact: Digital submissions, active pharmacovigilance and regional convergence will make dossier quality, safety-data flows and lifecycle controls far more visible to West African regulators. Organisations that still run the region through fragmented, paper-heavy, country-by-country processes face growing compliance and reputational risk.

Strategic Recommendation: Build regional regulatory and pharmacovigilance systems that supply consistent dossiers, safety information and product-quality data to multiple authorities. Start by getting ready for Senegal’s e-platform and adding any local iohexol or bupivacaine cases to your global safety database.

Sources: https://arp.sn/actualites/2026-10-14-reglementation-forte-autorite-credible-consolidation-nm3

Engage BethAri to design a West Africa regulatory operating model that scales across markets.